NEUROLOGICAL AND PSYCHIATRIC SIDE-EFFECTS OF L-DOPA

被引：12

作者：

BARBEAU, A ^{[1
]}

机构：

[1] CLIN RES INST MONTREAL, DEPT NEUROBIOL, MONTREAL H2W 1R7, QUEBEC, CANADA

来源：

PHARMACOLOGY & THERAPEUTICS PART C-CLINICAL PHARMACOLOGY AND THERAPEUTICS | 1976年 / 1卷 / 3-4期

关键词：

D O I：

10.1016/S0362-5486(76)80032-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：475 / 494

页数：20

共 66 条

[1] BEHAVIOURAL AND BIOCHEMICAL EFFECTS OF L-DOPA AFTER INHIBITION OF DOPAMINE-BETA-HYDROXYLASE IN RESERPINE PRETREATED RATS [J].

AHLENIUS, S ;

ENGEL, J .

NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE, 1971, 270 (04) :349-&

[2] EVIDENCE FOR DOPAMINE RECEPTOR STIMULATION BY APOMORPHINE [J].

ANDEN, NE ;

RUBENSON, A ;

FUXE, K ;

HOKFELT, T .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1967, 19 (09) :627-&

[3] EFFECTS OF CHLORPROMAZINE, HALOPERIDOL AND RESERPINE ON THE LEVELS OF PHENOLIC ACIDS IN RABBIT CORPUS STRIATUM [J].

ANDEN, NE ;

ROOS, BE ;

WERDINIUS, B .

LIFE SCIENCES, 1964, 3 (02) :149-158

[4] DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS [J].

ANDEN, NE ;

CARLSSON, A ;

DAHLSTROM, A ;

FUXE, K ;

HILLARP, NA ;

LARSSON, K .

LIFE SCIENCES, 1964, 3 (06) :523-530

[5]

BARBEAU A, 1969, CAN MED ASSOC J, V101, P791

[6]

BARBEAU A, 1972, Clinical Research, V20, P948

[7]

Barbeau A, 1972, Monogr Hum Genet, V6, P114

[8]

Barbeau A, 1974, Adv Neurol, V5, P347

[9]

BARBEAU A, 1970, CAN MED ASSOC J, V103, P824

[10]

BARBEAU A, 1969, LANCET, V2, P1066

← 1 2 3 4 5 6 7 →